Quick Answer
Virax Biolabs Group Ltd reported Total Assets of $6.43 million for fiscal year 2025.
Virax Biolabs Group Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.43M | +17.2% |
| 2024 | $5.48M | -44.1% |
| 2023 | $9.81M | +20046.2% |
| 2022 | $48.7K | +22.9% |
| 2021 | $39.6K | — |
- Virax Biolabs Group Ltd showed an increase of +17.2% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Virax Biolabs Group Ltd’s total assets has grown by 16121.0% (from $39.6 thousand to $6.43 million).
- The most recent figure is from Virax Biolabs Group Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 2, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: